Biomea Fusion, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
BMEA on Nasdaq
Industry
Pharmaceutical Preparations
Location
900 Middlefield Road, 4 Th Floor, Redwood City, CA

Insiders trading volume in the past year

Biomea Fusion, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sotirios Stergiopoulos Director $16.6M Sep 17, 2021
Bihua Chen Director, 10%+ Owner $15.8M Jun 12, 2024
A2A Pharmaceuticals, Inc. 10%+ Owner $13.2M May 31, 2023
Rainer M. Erdtmann President and COO, Director $3.73M Jan 17, 2024
Franco Valle Chief Financial Officer $265K +$55.4K +26.5% Nov 30, 2024
Michael J.M. Hitchcock Director $151K +$101K +200% Sep 30, 2024
Juan Pablo Frias Chief Medical Officer $3.12K May 31, 2024
Sumita Ray Director Jun 12, 2024
Thomas Andrew Butler Chief Executive Officer, Director, 10%+ Owner Jan 17, 2024
Biomea Health, LLC 10%+ Owner Jun 1, 2022
Elizabeth Faust Director Jun 12, 2024
Eric Aguiar Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Biomea Fusion, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.